BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 30914310)

  • 1. Second Primary Non-Small-Cell Lung Cancer After Head and Neck Cancer: A Population-Based Study of Clinical and Pathologic Characteristics and Survival Outcomes in 3597 Patients.
    Budnik J; DeNunzio NJ; Singh DP; Milano MT
    Clin Lung Cancer; 2020 May; 21(3):195-203. PubMed ID: 30914310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-small-cell lung cancer after breast cancer: a population-based study of clinicopathologic characteristics and survival outcomes in 3529 women.
    Milano MT; Strawderman RL; Venigalla S; Ng K; Travis LB
    J Thorac Oncol; 2014 Aug; 9(8):1081-90. PubMed ID: 25157761
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Second malignancy in non-small cell lung cancer (NSCLC): prevalence and overall survival (OS) in routine clinical practice.
    Faehling M; Schwenk B; Kramberg S; Fallscheer S; Leschke M; Sträter J; Eckert R
    J Cancer Res Clin Oncol; 2018 Oct; 144(10):2059-2066. PubMed ID: 30062488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survival after second primary lung cancer: a population-based study of 187 Hodgkin lymphoma patients.
    Milano MT; Li H; Constine LS; Travis LB
    Cancer; 2011 Dec; 117(24):5538-47. PubMed ID: 21692074
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinicopathological features, risk and survival in lung cancer survivors with therapy-related acute myeloid leukaemia.
    Wang H; Yin Y; Wang R; Huang J; Xue H; Cheng Y; Zhang L; Chen C
    BMC Cancer; 2020 Nov; 20(1):1081. PubMed ID: 33172389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term outcomes in radically treated synchronous vs. metachronous oligometastatic non-small-cell lung cancer.
    Fleckenstein J; Petroff A; Schäfers HJ; Wehler T; Schöpe J; Rübe C
    BMC Cancer; 2016 Jun; 16():348. PubMed ID: 27255302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Previous head and neck cancers portend poor prognoses in lung cancer patients.
    Jayaprakash V; Cheng C; Reid M; Dexter EU; Nwogu CE; Hicks W; Sullivan M; Demmy TL; Yendamuri S
    Ann Thorac Surg; 2011 Sep; 92(3):1056-60; discussion 1060-1. PubMed ID: 21871300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term survival trends in patients with unresectable stage III non-small cell lung cancer receiving chemotherapy and radiation therapy: a SEER cancer registry analysis.
    Hansen RN; Zhang Y; Seal B; Ryan K; Yong C; Darilay A; Ramsey SD
    BMC Cancer; 2020 Apr; 20(1):276. PubMed ID: 32248816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical characteristics and risk of second primary lung cancer after cervical cancer: A population-based study.
    Qian C; Liu H; Feng Y; Meng S; Wang D; Nie M; Xu M
    PLoS One; 2020; 15(8):e0231807. PubMed ID: 32756555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metachronous Second Primary Malignancies after Head and Neck Cancer in a Korean Cohort (1993-2010).
    Jung YS; Lim J; Jung KW; Ryu J; Won YJ
    PLoS One; 2015; 10(7):e0134160. PubMed ID: 26218068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment and survival of second primary early-stage lung cancer, following treatment of head and neck cancer in the Netherlands.
    Louie AV; Damhuis RA; Haasbeek CJ; Warner A; Rodin D; Slotman BJ; Leemans CR; Senan S
    Lung Cancer; 2016 Apr; 94():54-60. PubMed ID: 26973207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Second Primary Lung Cancer After Head and Neck Cancer: Implications for Screening Computed Tomography.
    Pagedar NA; Jayawardena A; Charlton ME; Hoffman HT
    Ann Otol Rhinol Laryngol; 2015 Oct; 124(10):765-9. PubMed ID: 25881583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes of local thoracic surgery in patients with stage IV non-small-cell lung cancer: A SEER-based analysis.
    Jia J; Guo B; Yang Z; Liu Y; Ga L; Xing G; Zhang S; Jin A; Ma R; Wang J
    Eur J Cancer; 2021 Feb; 144():326-340. PubMed ID: 33388490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survival results and prognostic factors in T4 N0-3 non-small cell lung cancer patients according to the AJCC 7th edition staging system.
    Arslan D; Bozcuk H; Gunduz S; Tural D; Tattli AM; Uysal M; Goksu SS; Bassorgun Cİ; Koral L; Coskun HS; Ozdogan M; Savas B
    Asian Pac J Cancer Prev; 2014; 15(6):2465-72. PubMed ID: 24761848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiation-induced cancer after radiotherapy for non-Hodgkin's lymphoma of the head and neck: a retrospective study.
    Toda K; Shibuya H; Hayashi K; Ayukawa F
    Radiat Oncol; 2009 Jul; 4():21. PubMed ID: 19591686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimizing Survival of Patients With Marginally Operable Stage IIIA Non-Small-Cell Lung Cancer Receiving Chemoradiotherapy With or Without Surgery.
    Yang KL; Chang YC; Ko HL; Chi MS; Wang HE; Hsu PS; Lin CC; Yeh DY; Kao SJ; Jiang JS; Chi KH
    Clin Lung Cancer; 2016 Nov; 17(6):550-557. PubMed ID: 27378175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Second primary lung cancers following a diagnosis of primary head and neck cancer.
    Griffioen GH; Louie AV; de Bree R; Smit EF; Paul MA; Slotman BJ; Leemans CR; Senan S
    Lung Cancer; 2015 Apr; 88(1):94-9. PubMed ID: 25662386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overall survival according to immunotherapy and radiation treatment for metastatic non-small-cell lung cancer: a National Cancer Database analysis.
    Foster CC; Sher DJ; Rusthoven CG; Verma V; Spiotto MT; Weichselbaum RR; Koshy M
    Radiat Oncol; 2019 Jan; 14(1):18. PubMed ID: 30691492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pulmonary Resection for Second Lung Cancer After Pneumonectomy: A Population-Based Study.
    Ayub A; Rehmani SS; Al-Ayoubi AM; Raad W; Flores RM; Bhora FY
    Ann Thorac Surg; 2017 Oct; 104(4):1131-1137. PubMed ID: 28709663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment strategies for stage IA non-small cell lung cancer: A SEER-based population study.
    Wu B; Zhang X; Feng N; Hu Z; Wu J; Zhou W; Wei Y; Zhang W; Wang K
    PLoS One; 2024; 19(4):e0298470. PubMed ID: 38683794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.